PharmaShots | Incisive News in 3 Shots

Subscribe Now

RSJ10333 Trial

Reistone Reports First Patient Dosing in P-III RSJ10333 Trial of SHR0302 for the Treatment of Atopic Dermatitis

Reistone Reports First Patient Dosing in P-III RSJ10333 Trial of SHR0302 for the Treatment of Atopic Dermatitis

May 14, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us